Cargando…

Prostate-Specific Antigen Bounce after (125)I Brachytherapy Using Stranded Seeds with Intraoperative Optimization for Prostate Cancer

SIMPLE SUMMARY: Our study investigated clinical features of prostate-specific antigen (PSA) bounce in patients undergoing brachytherapy. PSA bounce is common and discriminating between large bounces and biochemical failures is very difficult. Therefore, we suggest important points to discriminate be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae Hyung, Lee, Jason Joon Bock, Cho, Jaeho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563276/ https://www.ncbi.nlm.nih.gov/pubmed/36230829 http://dx.doi.org/10.3390/cancers14194907

Ejemplares similares

Dosimetric outcomes of preoperative treatment planning with intraoperative optimization using stranded seeds in prostate brachytherapy
por: Lee, Jason Joon Bock, et al.
Publicado: (2022)

Clinical features of prostate-specific antigen bounce after (125)I brachytherapy for prostate cancer
por: Kubo, Katsumaro, et al.
Publicado: (2018)

Permanent (125)I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence
por: Mazeron, Renaud, et al.
Publicado: (2012)

Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prostate brachytherapy
por: Hackett, Cian, et al.
Publicado: (2014)

Prostate-specific antigen bounce predicts for a favorable prognosis following brachytherapy: a meta-analysis
por: Bernstein, Michael B., et al.
Publicado: (2013)

Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy
por: Yamamoto, Yoichiro, et al.
Publicado: (2016)

Bioevaluation of (125)I Ocu-Prosta seeds for application in prostate cancer brachytherapy
por: Mukherjee, Archana, et al.
Publicado: (2014)

Late seed migration after prostate brachytherapy with Iod-125 permanent implants
por: Maletzki, Philipp, et al.
Publicado: (2018)

Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort
por: Leite, Elton Trigo Teixeira, et al.
Publicado: (2019)

Unexpected Seed Migration in Prostate Brachytherapy Implants Coincident with Change in Seed Stranding Product
por: Rose, Jim, et al.
Publicado: (2017)

Prostate-Specific Antigen Bounce Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Vu, Charles C., et al.
Publicado: (2014)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

Safety and efficacy of iodine-125 seed strand for intraluminal brachytherapy on ureteral carcinoma
por: Bi, Yonghua, et al.
Publicado: (2023)

Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?
por: Taussky, Daniel, et al.
Publicado: (2017)

Plan reproducibility of intraoperatively custom-built linked seeds compared to loose seeds for prostate brachytherapy
por: Kaneda, Tomoya, et al.
Publicado: (2018)

Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy
por: Hirose, Katsumi, et al.
Publicado: (2017)

Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review
por: Zuber, Simon, et al.
Publicado: (2015)

Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer
por: Moll, Matthias, et al.
Publicado: (2021)

Dosimetry advantages of intraoperatively built custom-linked seeds compared with loose seeds in permanent prostate brachytherapy
por: Inada, Masahiro, et al.
Publicado: (2017)

Reducing seed waste and increasing value of dynamic intraoperative implantation of Pd‐103 seeds in prostate brachytherapy
por: Taylor, Peter K., et al.
Publicado: (2018)

Seed Density as a New Predictive Index of Seed Migration in Brachytherapy for Prostate Cancer Using Iodine-125 Loose Seed
por: Yamaguchi, Takahiro, et al.
Publicado: (2023)

Photoacoustic imaging of prostate brachytherapy seeds
por: Su, Jimmy L., et al.
Publicado: (2011)

Prostate brachytherapy: HDR or seed implant
por: Das, K. R.
Publicado: (2006)

Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose (125)I seeds
por: Sugawara, Akitomo, et al.
Publicado: (2011)

Correlations between intraplan and postplan parameters in I-125 permanent prostate brachytherapy using loose seeds or linked seeds
por: Ito, Fumitaka, et al.
Publicado: (2022)

Iodine-125 prostate seed brachytherapy in renal transplant recipients: an analysis of oncological outcomes and toxicity profile
por: Beydoun, Nadine, et al.
Publicado: (2014)

Biliary drainage combined with simultaneous (125)I seed strand brachytherapy for the treatment of hilar cholangiocarcinoma
por: Zhang, Chengzhi, et al.
Publicado: (2023)

Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
por: Njomnang Soh, Patrice, et al.
Publicado: (2013)

Prostate specific antigen bounce after intensity-modulated radiation therapy in an Asian population
por: Tan, Yu Guang, et al.
Publicado: (2016)

Toxicity in patients treated with permanent prostate brachytherapy using intraoperatively built custom-linked seeds versus loose seeds
por: Ollivier, Luc, et al.
Publicado: (2020)

Clinical outcomes of intraluminal Iodine-125 seed strand brachytherapy and percutaneous nephrostomy in patients with ureteral carcinoma
por: Bi, Yonghua, et al.
Publicado: (2023)

A machine-learning approach based on 409 treatments to predict optimal number of iodine-125 seeds in low-dose-rate prostate brachytherapy
por: Boussion, Nicolas, et al.
Publicado: (2021)

Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy
por: Makino, Tomoyuki, et al.
Publicado: (2016)

Evaluation of an automated seed loader for seed calibration in prostate brachytherapy
por: Wan, Shuying, et al.
Publicado: (2006)

Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative prostate brachytherapy
por: Martell, Kevin, et al.
Publicado: (2017)

Automated estimation of number of implanted iodine-125 seeds for prostate brachytherapy based on two-view analysis of pelvic radiographs
por: Kawata, Hidemichi, et al.
Publicado: (2012)

Endovascular brachytherapy with iodine-125 seed strand for extensive portal vein tumor thrombus in patients with hepatocellular carcinoma
por: Tan, Zhongbao, et al.
Publicado: (2023)

Comparison between preoperative and real-time intraoperative planning (125)I permanent prostate brachytherapy: long-term clinical biochemical outcome
por: Matzkin, Haim, et al.
Publicado: (2013)

Re-implantation after insufficient primary 125-i permanent prostate brachytherapy
por: Putora, Paul Martin, et al.
Publicado: (2013)

Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer
por: Harada, Kosaku, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ntbvtp08pmbli3hlq7rbd03i9e